Subscribe Now »

Special Holiday Deal

Give the Gift of the

Give one person a magazine subscription for $29.95, and get each additional subscription for just $19.95.


I would like to receive the following free email newsletters:

Newsletter Signup
  1. Bridal Party
  2. Dining Out
  3. Kliman Online
  4. Photo Ops
  5. Shop Around
  6. Where & When
  7. Well+Being
  8. Learn more
Matthew Schumaker: 40 Under 40
The young lobbyists with the most influence in Washington By Marisa M. Kashino
Comments () | Published May 23, 2011

Name: Matthew Schumaker
Firm: Biotechnology Industry Organization
Age: 31

As the chief Democratic lobbyist for the trade association that represents more than a thousand biotechnology companies, research centers, and universities, Schumaker has a broad mandate to protect innovation.

Patent reform is currently at the top of his agenda. He successfully worked to strip language harmful to his industry about damages in patent-infringement cases from the Senate’s version of the legislation, which passed in March. Another key win came during the debate over health-care reform, when he fought to get a provision included in the bill to give the Food and Drug Administration the authority to approve biosimilars, or generic biologic drugs—a power that will help protect financial incentives for his group’s member companies.

This article appears in the June 2011 issue of The Washingtonian.

Subscribe to Washingtonian
Follow Washingtonian on Twitter


People & Politics
Subscribe to Washingtonian

Discuss this story

Feel free to leave a comment or ask a question. The Washingtonian reserves the right to remove or edit content once posted.
blog comments powered by Disqus

Posted at 07:00 AM/ET, 05/23/2011 RSS | Print | Permalink | Comments () | Articles